IgE Allergy Blood Tests Market Size & Share, by Product Type {Assays & Kits, ELISA Testing Kits, Fluorescent Enzyme Immunoassays (FEIA) Testing Kits, Chemiluminescent Immunoassays (CLIA)}; Application (Aero Allergies, Indoor Allergies, Outdoor Allergies, Food Allergies, Venoms); End-User (Diagnostic Laboratories, Specialty Clinics, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5551
  • Published Date: Jan 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the IgE Allergy Blood Tests Market

    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis  
    • Eurofins Viracor
    • Neogen Corporation
    • Omega Diagnostics PLC
    • Abionic SA
    • Amerimmune LLC
    • AXO Science
    • Biovator AB
    • China Medical Technologies Inc
    • Cytognos, SL

Browse Key Market Insights with Data Illustration:


In The News

  • The U.S. Food & Drug Administration (FDA) has cleared Thermo Fisher Scientific's ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies. These cutting-edge blood tests, which are also anticipated to be made available countrywide, can serve as a diagnostic tool for physicians and other healthcare professionals by assisting in the identification of wheat and sesame allergies in patients who may experience a severe allergic reaction.
  • Leading provider of immunology and infectious disease testing, Eurofins Viracor, officially opened its new, large laboratory in Lenexa, Kansas, today. With 215 current employees and 235 newly created roles, the 110,000 square foot, state-of-the-art facility will employ 450 people and provide additional capacity to support development in biopharma and transplant diagnostic testing services.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5551
  • Published Date: Jan 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are a surge in pollution levels, growing utilization of mHealth, and rising prevalence of food allergies.

The market size of IgE allergy blood tests is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market are Thermo Fisher Scientific, Inc., Eurofins Viracor, Neogen Corporation, Omega Diagnostics PLC and others.

The diagnostics laboratories segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying